[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Small Molecule Innovator CDMO Market Growth 2022-2028

December 2022 | 106 pages | ID: G809CA42F19DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Small Molecule Innovator CDMO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Small Molecule Innovator CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Small Molecule Innovator CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Small Molecule Innovator CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Small Molecule Innovator CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Small Molecule Innovator CDMO players cover Lonza Group, Thermo Fisher Scientific, Cambrex Corporation, CATALENT and Siegfried Holding AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Small Molecule Innovator CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Small Molecule Innovator CDMO market, with both quantitative and qualitative data, to help readers understand how the Small Molecule Innovator CDMO market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Small Molecule Innovator CDMO market and forecasts the market size by Type (Oral Solid Dosage Form and Semi-solid Dosage Form,), by Application (Pharmaceutical and Biotech Companies, Academic and Research Institutions and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • Oral Solid Dosage Form
  • Semi-solid Dosage Form
Segmentation by application
  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutions
  • Others
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Lonza Group
  • Thermo Fisher Scientific
  • Cambrex Corporation
  • CATALENT
  • Siegfried Holding AG
  • Recipharm AB
  • CordenPharma International
  • Boehringer Ingelheim
  • Piramal Pharma Solutions
  • Covance
Chapter Introduction

Chapter 1: Scope of Small Molecule Innovator CDMO, Research Methodology, etc.

Chapter 2: Executive Summary, global Small Molecule Innovator CDMO market size (sales and revenue) and CAGR, Small Molecule Innovator CDMO market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Small Molecule Innovator CDMO sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Small Molecule Innovator CDMO sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Small Molecule Innovator CDMO market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Thermo Fisher Scientific, Cambrex Corporation, CATALENT, Siegfried Holding AG, Recipharm AB, CordenPharma International, Boehringer Ingelheim and Piramal Pharma Solutions, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Small Molecule Innovator CDMO Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Small Molecule Innovator CDMO by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Small Molecule Innovator CDMO by Country/Region, 2017, 2022 & 2028
2.2 Small Molecule Innovator CDMO Segment by Type
  2.2.1 Oral Solid Dosage Form
  2.2.2 Semi-solid Dosage Form
2.3 Small Molecule Innovator CDMO Sales by Type
  2.3.1 Global Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
  2.3.2 Global Small Molecule Innovator CDMO Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Small Molecule Innovator CDMO Sale Price by Type (2017-2022)
2.4 Small Molecule Innovator CDMO Segment by Application
  2.4.1 Pharmaceutical and Biotech Companies
  2.4.2 Academic and Research Institutions
  2.4.3 Others
2.5 Small Molecule Innovator CDMO Sales by Application
  2.5.1 Global Small Molecule Innovator CDMO Sale Market Share by Application (2017-2022)
  2.5.2 Global Small Molecule Innovator CDMO Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Small Molecule Innovator CDMO Sale Price by Application (2017-2022)

3 GLOBAL SMALL MOLECULE INNOVATOR CDMO BY COMPANY

3.1 Global Small Molecule Innovator CDMO Breakdown Data by Company
  3.1.1 Global Small Molecule Innovator CDMO Annual Sales by Company (2020-2022)
  3.1.2 Global Small Molecule Innovator CDMO Sales Market Share by Company (2020-2022)
3.2 Global Small Molecule Innovator CDMO Annual Revenue by Company (2020-2022)
  3.2.1 Global Small Molecule Innovator CDMO Revenue by Company (2020-2022)
  3.2.2 Global Small Molecule Innovator CDMO Revenue Market Share by Company (2020-2022)
3.3 Global Small Molecule Innovator CDMO Sale Price by Company
3.4 Key Manufacturers Small Molecule Innovator CDMO Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Small Molecule Innovator CDMO Product Location Distribution
  3.4.2 Players Small Molecule Innovator CDMO Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SMALL MOLECULE INNOVATOR CDMO BY GEOGRAPHIC REGION

4.1 World Historic Small Molecule Innovator CDMO Market Size by Geographic Region (2017-2022)
  4.1.1 Global Small Molecule Innovator CDMO Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Small Molecule Innovator CDMO Annual Revenue by Geographic Region
4.2 World Historic Small Molecule Innovator CDMO Market Size by Country/Region (2017-2022)
  4.2.1 Global Small Molecule Innovator CDMO Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Small Molecule Innovator CDMO Annual Revenue by Country/Region
4.3 Americas Small Molecule Innovator CDMO Sales Growth
4.4 APAC Small Molecule Innovator CDMO Sales Growth
4.5 Europe Small Molecule Innovator CDMO Sales Growth
4.6 Middle East & Africa Small Molecule Innovator CDMO Sales Growth

5 AMERICAS

5.1 Americas Small Molecule Innovator CDMO Sales by Country
  5.1.1 Americas Small Molecule Innovator CDMO Sales by Country (2017-2022)
  5.1.2 Americas Small Molecule Innovator CDMO Revenue by Country (2017-2022)
5.2 Americas Small Molecule Innovator CDMO Sales by Type
5.3 Americas Small Molecule Innovator CDMO Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Small Molecule Innovator CDMO Sales by Region
  6.1.1 APAC Small Molecule Innovator CDMO Sales by Region (2017-2022)
  6.1.2 APAC Small Molecule Innovator CDMO Revenue by Region (2017-2022)
6.2 APAC Small Molecule Innovator CDMO Sales by Type
6.3 APAC Small Molecule Innovator CDMO Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Small Molecule Innovator CDMO by Country
  7.1.1 Europe Small Molecule Innovator CDMO Sales by Country (2017-2022)
  7.1.2 Europe Small Molecule Innovator CDMO Revenue by Country (2017-2022)
7.2 Europe Small Molecule Innovator CDMO Sales by Type
7.3 Europe Small Molecule Innovator CDMO Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Small Molecule Innovator CDMO by Country
  8.1.1 Middle East & Africa Small Molecule Innovator CDMO Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Small Molecule Innovator CDMO Revenue by Country (2017-2022)
8.2 Middle East & Africa Small Molecule Innovator CDMO Sales by Type
8.3 Middle East & Africa Small Molecule Innovator CDMO Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Small Molecule Innovator CDMO
10.3 Manufacturing Process Analysis of Small Molecule Innovator CDMO
10.4 Industry Chain Structure of Small Molecule Innovator CDMO

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Small Molecule Innovator CDMO Distributors
11.3 Small Molecule Innovator CDMO Customer

12 WORLD FORECAST REVIEW FOR SMALL MOLECULE INNOVATOR CDMO BY GEOGRAPHIC REGION

12.1 Global Small Molecule Innovator CDMO Market Size Forecast by Region
  12.1.1 Global Small Molecule Innovator CDMO Forecast by Region (2023-2028)
  12.1.2 Global Small Molecule Innovator CDMO Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Small Molecule Innovator CDMO Forecast by Type
12.7 Global Small Molecule Innovator CDMO Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Lonza Group
  13.1.1 Lonza Group Company Information
  13.1.2 Lonza Group Small Molecule Innovator CDMO Product Offered
  13.1.3 Lonza Group Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Lonza Group Main Business Overview
  13.1.5 Lonza Group Latest Developments
13.2 Thermo Fisher Scientific
  13.2.1 Thermo Fisher Scientific Company Information
  13.2.2 Thermo Fisher Scientific Small Molecule Innovator CDMO Product Offered
  13.2.3 Thermo Fisher Scientific Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Thermo Fisher Scientific Main Business Overview
  13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Cambrex Corporation
  13.3.1 Cambrex Corporation Company Information
  13.3.2 Cambrex Corporation Small Molecule Innovator CDMO Product Offered
  13.3.3 Cambrex Corporation Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Cambrex Corporation Main Business Overview
  13.3.5 Cambrex Corporation Latest Developments
13.4 CATALENT
  13.4.1 CATALENT Company Information
  13.4.2 CATALENT Small Molecule Innovator CDMO Product Offered
  13.4.3 CATALENT Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 CATALENT Main Business Overview
  13.4.5 CATALENT Latest Developments
13.5 Siegfried Holding AG
  13.5.1 Siegfried Holding AG Company Information
  13.5.2 Siegfried Holding AG Small Molecule Innovator CDMO Product Offered
  13.5.3 Siegfried Holding AG Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Siegfried Holding AG Main Business Overview
  13.5.5 Siegfried Holding AG Latest Developments
13.6 Recipharm AB
  13.6.1 Recipharm AB Company Information
  13.6.2 Recipharm AB Small Molecule Innovator CDMO Product Offered
  13.6.3 Recipharm AB Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Recipharm AB Main Business Overview
  13.6.5 Recipharm AB Latest Developments
13.7 CordenPharma International
  13.7.1 CordenPharma International Company Information
  13.7.2 CordenPharma International Small Molecule Innovator CDMO Product Offered
  13.7.3 CordenPharma International Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 CordenPharma International Main Business Overview
  13.7.5 CordenPharma International Latest Developments
13.8 Boehringer Ingelheim
  13.8.1 Boehringer Ingelheim Company Information
  13.8.2 Boehringer Ingelheim Small Molecule Innovator CDMO Product Offered
  13.8.3 Boehringer Ingelheim Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Boehringer Ingelheim Main Business Overview
  13.8.5 Boehringer Ingelheim Latest Developments
13.9 Piramal Pharma Solutions
  13.9.1 Piramal Pharma Solutions Company Information
  13.9.2 Piramal Pharma Solutions Small Molecule Innovator CDMO Product Offered
  13.9.3 Piramal Pharma Solutions Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Piramal Pharma Solutions Main Business Overview
  13.9.5 Piramal Pharma Solutions Latest Developments
13.10 Covance
  13.10.1 Covance Company Information
  13.10.2 Covance Small Molecule Innovator CDMO Product Offered
  13.10.3 Covance Small Molecule Innovator CDMO Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Covance Main Business Overview
  13.10.5 Covance Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Small Molecule Innovator CDMO Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Small Molecule Innovator CDMO Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Solid Dosage Form
Table 4. Major Players of Semi-solid Dosage Form
Table 5. Global Small Molecule Innovator CDMO Sales by Type (2017-2022) & (K Units)
Table 6. Global Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
Table 7. Global Small Molecule Innovator CDMO Revenue by Type (2017-2022) & ($ million)
Table 8. Global Small Molecule Innovator CDMO Revenue Market Share by Type (2017-2022)
Table 9. Global Small Molecule Innovator CDMO Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Small Molecule Innovator CDMO Sales by Application (2017-2022) & (K Units)
Table 11. Global Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Table 12. Global Small Molecule Innovator CDMO Revenue by Application (2017-2022)
Table 13. Global Small Molecule Innovator CDMO Revenue Market Share by Application (2017-2022)
Table 14. Global Small Molecule Innovator CDMO Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Small Molecule Innovator CDMO Sales by Company (2020-2022) & (K Units)
Table 16. Global Small Molecule Innovator CDMO Sales Market Share by Company (2020-2022)
Table 17. Global Small Molecule Innovator CDMO Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Small Molecule Innovator CDMO Revenue Market Share by Company (2020-2022)
Table 19. Global Small Molecule Innovator CDMO Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Small Molecule Innovator CDMO Producing Area Distribution and Sales Area
Table 21. Players Small Molecule Innovator CDMO Products Offered
Table 22. Small Molecule Innovator CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Small Molecule Innovator CDMO Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Small Molecule Innovator CDMO Sales Market Share Geographic Region (2017-2022)
Table 27. Global Small Molecule Innovator CDMO Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Small Molecule Innovator CDMO Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Small Molecule Innovator CDMO Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Small Molecule Innovator CDMO Sales Market Share by Country/Region (2017-2022)
Table 31. Global Small Molecule Innovator CDMO Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Small Molecule Innovator CDMO Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Small Molecule Innovator CDMO Sales by Country (2017-2022) & (K Units)
Table 34. Americas Small Molecule Innovator CDMO Sales Market Share by Country (2017-2022)
Table 35. Americas Small Molecule Innovator CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Small Molecule Innovator CDMO Revenue Market Share by Country (2017-2022)
Table 37. Americas Small Molecule Innovator CDMO Sales by Type (2017-2022) & (K Units)
Table 38. Americas Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
Table 39. Americas Small Molecule Innovator CDMO Sales by Application (2017-2022) & (K Units)
Table 40. Americas Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Table 41. APAC Small Molecule Innovator CDMO Sales by Region (2017-2022) & (K Units)
Table 42. APAC Small Molecule Innovator CDMO Sales Market Share by Region (2017-2022)
Table 43. APAC Small Molecule Innovator CDMO Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Small Molecule Innovator CDMO Revenue Market Share by Region (2017-2022)
Table 45. APAC Small Molecule Innovator CDMO Sales by Type (2017-2022) & (K Units)
Table 46. APAC Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
Table 47. APAC Small Molecule Innovator CDMO Sales by Application (2017-2022) & (K Units)
Table 48. APAC Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Table 49. Europe Small Molecule Innovator CDMO Sales by Country (2017-2022) & (K Units)
Table 50. Europe Small Molecule Innovator CDMO Sales Market Share by Country (2017-2022)
Table 51. Europe Small Molecule Innovator CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Small Molecule Innovator CDMO Revenue Market Share by Country (2017-2022)
Table 53. Europe Small Molecule Innovator CDMO Sales by Type (2017-2022) & (K Units)
Table 54. Europe Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
Table 55. Europe Small Molecule Innovator CDMO Sales by Application (2017-2022) & (K Units)
Table 56. Europe Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Small Molecule Innovator CDMO Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Small Molecule Innovator CDMO Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Small Molecule Innovator CDMO Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Small Molecule Innovator CDMO Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Small Molecule Innovator CDMO Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Small Molecule Innovator CDMO Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Small Molecule Innovator CDMO Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Small Molecule Innovator CDMO
Table 66. Key Market Challenges & Risks of Small Molecule Innovator CDMO
Table 67. Key Industry Trends of Small Molecule Innovator CDMO
Table 68. Small Molecule Innovator CDMO Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Small Molecule Innovator CDMO Distributors List
Table 71. Small Molecule Innovator CDMO Customer List
Table 72. Global Small Molecule Innovator CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Small Molecule Innovator CDMO Sales Market Forecast by Region
Table 74. Global Small Molecule Innovator CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Small Molecule Innovator CDMO Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Small Molecule Innovator CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Small Molecule Innovator CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Small Molecule Innovator CDMO Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Small Molecule Innovator CDMO Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Small Molecule Innovator CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Small Molecule Innovator CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Small Molecule Innovator CDMO Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Small Molecule Innovator CDMO Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Small Molecule Innovator CDMO Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Small Molecule Innovator CDMO Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Small Molecule Innovator CDMO Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Small Molecule Innovator CDMO Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Small Molecule Innovator CDMO Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Small Molecule Innovator CDMO Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Small Molecule Innovator CDMO Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Small Molecule Innovator CDMO Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lonza Group Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 93. Lonza Group Small Molecule Innovator CDMO Product Offered
Table 94. Lonza Group Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lonza Group Main Business
Table 96. Lonza Group Latest Developments
Table 97. Thermo Fisher Scientific Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 98. Thermo Fisher Scientific Small Molecule Innovator CDMO Product Offered
Table 99. Thermo Fisher Scientific Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Thermo Fisher Scientific Main Business
Table 101. Thermo Fisher Scientific Latest Developments
Table 102. Cambrex Corporation Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 103. Cambrex Corporation Small Molecule Innovator CDMO Product Offered
Table 104. Cambrex Corporation Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Cambrex Corporation Main Business
Table 106. Cambrex Corporation Latest Developments
Table 107. CATALENT Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 108. CATALENT Small Molecule Innovator CDMO Product Offered
Table 109. CATALENT Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. CATALENT Main Business
Table 111. CATALENT Latest Developments
Table 112. Siegfried Holding AG Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 113. Siegfried Holding AG Small Molecule Innovator CDMO Product Offered
Table 114. Siegfried Holding AG Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Siegfried Holding AG Main Business
Table 116. Siegfried Holding AG Latest Developments
Table 117. Recipharm AB Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 118. Recipharm AB Small Molecule Innovator CDMO Product Offered
Table 119. Recipharm AB Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Recipharm AB Main Business
Table 121. Recipharm AB Latest Developments
Table 122. CordenPharma International Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 123. CordenPharma International Small Molecule Innovator CDMO Product Offered
Table 124. CordenPharma International Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CordenPharma International Main Business
Table 126. CordenPharma International Latest Developments
Table 127. Boehringer Ingelheim Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 128. Boehringer Ingelheim Small Molecule Innovator CDMO Product Offered
Table 129. Boehringer Ingelheim Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Boehringer Ingelheim Main Business
Table 131. Boehringer Ingelheim Latest Developments
Table 132. Piramal Pharma Solutions Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 133. Piramal Pharma Solutions Small Molecule Innovator CDMO Product Offered
Table 134. Piramal Pharma Solutions Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Piramal Pharma Solutions Main Business
Table 136. Piramal Pharma Solutions Latest Developments
Table 137. Covance Basic Information, Small Molecule Innovator CDMO Manufacturing Base, Sales Area and Its Competitors
Table 138. Covance Small Molecule Innovator CDMO Product Offered
Table 139. Covance Small Molecule Innovator CDMO Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Covance Main Business
Table 141. Covance Latest Developments

LIST OF FIGURES

Figure 1. Picture of Small Molecule Innovator CDMO
Figure 2. Small Molecule Innovator CDMO Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Small Molecule Innovator CDMO Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Small Molecule Innovator CDMO Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Small Molecule Innovator CDMO Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Solid Dosage Form
Figure 10. Product Picture of Semi-solid Dosage Form
Figure 11. Global Small Molecule Innovator CDMO Sales Market Share by Type in 2021
Figure 12. Global Small Molecule Innovator CDMO Revenue Market Share by Type (2017-2022)
Figure 13. Small Molecule Innovator CDMO Consumed in Pharmaceutical and Biotech Companies
Figure 14. Global Small Molecule Innovator CDMO Market: Pharmaceutical and Biotech Companies (2017-2022) & (K Units)
Figure 15. Small Molecule Innovator CDMO Consumed in Academic and Research Institutions
Figure 16. Global Small Molecule Innovator CDMO Market: Academic and Research Institutions (2017-2022) & (K Units)
Figure 17. Small Molecule Innovator CDMO Consumed in Others
Figure 18. Global Small Molecule Innovator CDMO Market: Others (2017-2022) & (K Units)
Figure 19. Global Small Molecule Innovator CDMO Sales Market Share by Application (2017-2022)
Figure 20. Global Small Molecule Innovator CDMO Revenue Market Share by Application in 2021
Figure 21. Small Molecule Innovator CDMO Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Small Molecule Innovator CDMO Revenue Market Share by Company in 2021
Figure 23. Global Small Molecule Innovator CDMO Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Small Molecule Innovator CDMO Revenue Market Share by Geographic Region in 2021
Figure 25. Global Small Molecule Innovator CDMO Sales Market Share by Region (2017-2022)
Figure 26. Global Small Molecule Innovator CDMO Revenue Market Share by Country/Region in 2021
Figure 27. Americas Small Molecule Innovator CDMO Sales 2017-2022 (K Units)
Figure 28. Americas Small Molecule Innovator CDMO Revenue 2017-2022 ($ Millions)
Figure 29. APAC Small Molecule Innovator CDMO Sales 2017-2022 (K Units)
Figure 30. APAC Small Molecule Innovator CDMO Revenue 2017-2022 ($ Millions)
Figure 31. Europe Small Molecule Innovator CDMO Sales 2017-2022 (K Units)
Figure 32. Europe Small Molecule Innovator CDMO Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Small Molecule Innovator CDMO Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Small Molecule Innovator CDMO Revenue 2017-2022 ($ Millions)
Figure 35. Americas Small Molecule Innovator CDMO Sales Market Share by Country in 2021
Figure 36. Americas Small Molecule Innovator CDMO Revenue Market Share by Country in 2021
Figure 37. United States Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Small Molecule Innovator CDMO Sales Market Share by Region in 2021
Figure 42. APAC Small Molecule Innovator CDMO Revenue Market Share by Regions in 2021
Figure 43. China Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Small Molecule Innovator CDMO Sales Market Share by Country in 2021
Figure 50. Europe Small Molecule Innovator CDMO Revenue Market Share by Country in 2021
Figure 51. Germany Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Small Molecule Innovator CDMO Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Small Molecule Innovator CDMO Revenue Market Share by Country in 2021
Figure 58. Egypt Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Small Molecule Innovator CDMO Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Small Molecule Innovator CDMO in 2021
Figure 64. Manufacturing Process Analysis of Small Molecule Innovator CDMO
Figure 65. Industry Chain Structure of Small Molecule Innovator CDMO
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


More Publications